Hirsch IB, Xu Y, Davis KL, Calingaert B. Patient factors associated with glucagonlike peptide 1 receptor agonist use with and without insulin. Endocr Pract. 2011 Sep 1;17(5):707-16.
Evans MF, Poulos C, Smith VK. Who counts in evaluating the effects of air pollution policies on households? Non-market valuation in the presence of dependencies. J Environ Econ Manage. 2011 Jul 1;62(1):65-79.
Tunceli K, Pladevall-Vila M, Williams LK, Divine GW, Simpkins JC, Nag SS, Sajjan SG, Kamal-Bahl SJ, Alexander CM, Lafata JE. Trends in lipid management among patients with diabetes. Endocr Pract. 2006 Jul;12(4):380-7.
Michels KB, Rothman KJ. Update on unethical use of placebos in randomised trials. Bioethics. 2003 Apr;17(2):188-204.
Smith VK, Mansfield CA. Buying time: real and hypothetical offers. J Environ Econ Manage. 1998;36(3):209-24.